Shenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit

MT Newswires Live

2025/11/18

Shenzhen YHLO Biotech (SHA:688575) obtained medical device registration from the Guangdong regulator for its soluble CD146 chemiluminescence detection kit, according to a Tuesday filing with the Shanghai bourse.

The test aids in diagnosing central nervous system inflammatory demyelinating diseases, autoimmune encephalitis spectrum disorders and infectious diseases of the central nervous system.

Shares of the biotechnology company closed 1% lower Tuesday.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2584981750"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2584981750\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2584981750?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-18 15:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584981750","market":"fut","top_or_hot":-1,"title":"Shenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit","media":"MT Newswires Live","content":"<html><body><p> Shenzhen YHLO Biotech (SHA:688575) obtained medical device registration from the Guangdong regulator for its soluble CD146 chemiluminescence detection kit, according to a Tuesday filing with the Shanghai bourse.</p><p>The test aids in diagnosing central nervous system inflammatory demyelinating diseases, autoimmune encephalitis spectrum disorders and infectious diseases of the central nervous system.</p><p>Shares of the biotechnology company closed 1% lower Tuesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShenzhen YHLO Biotech Gets Guangdong, China Regulatory Approval for Detection Kit\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-11-18 15:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Shenzhen YHLO Biotech (SHA:688575) obtained medical device registration from the Guangdong regulator for its soluble CD146 chemiluminescence detection kit, according to a Tuesday filing with the Shanghai bourse.</p><p>The test aids in diagnosing central nervous system inflammatory demyelinating diseases, autoimmune encephalitis spectrum disorders and infectious diseases of the central nervous system.</p><p>Shares of the biotechnology company closed 1% lower Tuesday.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999002950.SGD","symbol_name":"United Asian Growth Opportunities SGD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2584981750","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584981750","pubTimestamp":1763451778,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shenzhen YHLO Biotech  obtained medical device registration from the Guangdong regulator for its soluble CD146 chemiluminescence detection kit, according to a Tuesday filing with the Shanghai bourse.The test aids in diagnosing central nervous system inflammatory demyelinating diseases, autoimmune encephalitis spectrum disorders and infectious diseases of the central nervous system.Shares of the biotechnology company closed 1% lower Tuesday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688575":"亚辉龙","SG9999002950.SGD":"United Asian Growth Opportunities SGD","SG9999003826.SGD":"日兴资管新加坡股息基金 SGD","A7RU.SI":"吉宝基础设施信托","SG9999001069.SGD":"UOB UNITED ASIA PACIFIC GROWTH (SGD) ACC","SG9999003461.SGD":"United Asia Pacific Infrastructure SGD","BK6031":"特种化学制品","BK0239":"医药制造","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD","BK6102":"燃气公用事业","BK6501":"化工股"},"translate_title":"深圳YHLO Biotech检测试剂盒获得中国广东监管部门批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688575":0.9,"A7RU.SI":1.5},"content_text":"Shenzhen YHLO Biotech (SHA:688575) obtained medical device registration from the Guangdong regulator for its soluble CD146 chemiluminescence detection kit, according to a Tuesday filing with the Shanghai bourse.The test aids in diagnosing central nervous system inflammatory demyelinating diseases, autoimmune encephalitis spectrum disorders and infectious diseases of the central nervous system.Shares of the biotechnology company closed 1% lower Tuesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}